GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $678,000 | -36.4% | 164,500 | +98.4% | 0.00% | -50.0% |
| Q4 2021 | $1,066,000 | +257.7% | 82,900 | +200.4% | 0.00% | +100.0% |
| Q3 2021 | $298,000 | +10.0% | 27,600 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $271,000 | -3.2% | 29,700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $280,000 | +120.5% | 29,700 | -38.1% | 0.00% | – |
| Q3 2020 | $127,000 | -62.5% | 48,000 | -5.9% | 0.00% | -100.0% |
| Q2 2020 | $339,000 | +51.3% | 51,000 | +32.5% | 0.00% | 0.0% |
| Q1 2020 | $224,000 | -33.1% | 38,500 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $335,000 | +3.7% | 37,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $323,000 | +191.0% | 37,400 | +274.0% | 0.00% | – |
| Q2 2019 | $111,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |